These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats. Chan V; Hoey A; Brown L Br J Pharmacol; 2006 Aug; 148(7):902-8. PubMed ID: 16783413 [TBL] [Abstract][Full Text] [Related]
43. Preventive effect of angiotensin I on weight reduction in the adrenal glands of DOCA/salt hypertensive rats. Watanabe M; Honda M; Soma M; Minato M; Fukuda N; Watanabe Y; Izumi Y; Hatano M Endocrinol Jpn; 1990 Aug; 37(4):521-8. PubMed ID: 2083530 [TBL] [Abstract][Full Text] [Related]
44. Overflow of endogenous norepinephrine from PVH nucleus of DOCA-salt hypertensive rats. Qualy JM; Westfall TC Am J Physiol; 1995 Apr; 268(4 Pt 2):H1549-54. PubMed ID: 7733356 [TBL] [Abstract][Full Text] [Related]
46. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension. Wang H; McNeill JR Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814 [TBL] [Abstract][Full Text] [Related]
47. Function of the isolated perfused kidneys from young or adult rats with post-DOCA-salt hypertension. Vanecková I; Kunes J; Jelínek J Clin Exp Hypertens; 1999 May; 21(4):407-21. PubMed ID: 10369383 [TBL] [Abstract][Full Text] [Related]
48. Selective distribution of medial thickening in the renal vessels in experimental hypertension. Chen Q; Okeda R; Matsuo T Pathol Int; 1994 Aug; 44(8):569-77. PubMed ID: 7952146 [TBL] [Abstract][Full Text] [Related]
49. Baroreflex sensitivity and susceptibility to systolic hypertension induced by DOCA-salt in the Sabra rat. Weinstock M; Schorer-Apelbaum D; Ben-Ishay D Am J Physiol; 1984 Mar; 246(3 Pt 2):H448-52. PubMed ID: 6703079 [TBL] [Abstract][Full Text] [Related]
50. Altered disposition of vascular catecholamines in hypertensive (DOCA-salt) rats. Crabb GA; Head RJ; Hempstead J; Berkowitz BA Clin Exp Hypertens (1978); 1980; 2(1):129-38. PubMed ID: 7418539 [TBL] [Abstract][Full Text] [Related]
51. Aqueduct block markedly reduces mortality and hypertension in post-deoxycorticosterone acetate Dahl salt-resistant rats. Lee JY; Tobian L Hypertension; 1991 Jun; 17(6 Pt 2):1197-203. PubMed ID: 2045165 [TBL] [Abstract][Full Text] [Related]
52. Afferent arteriolar diameter in DOCA-salt and two-kidney one-clip hypertensive rats. Iversen BM; Mørkrid L; Ofstad J Am J Physiol; 1983 Dec; 245(6):F755-62. PubMed ID: 6362430 [TBL] [Abstract][Full Text] [Related]
54. Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension. Wang Y; Wang DH Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1550-9. PubMed ID: 19794112 [TBL] [Abstract][Full Text] [Related]
55. Remodelling of the heart in DOCA-salt hypertensive rats by propranolol and by an alpha-2 agonist, rilmenidine. Callens-el Amrani F; Paolaggi F; Swynghedauw B J Hypertens; 1989 Dec; 7(12):947-54. PubMed ID: 2576430 [TBL] [Abstract][Full Text] [Related]